August 25, 2016 4:06 PM ET

Pharmaceuticals

Company Overview of Unilab (Philippines) Inc.

Company Overview

Unilab (Philippines) Inc. operates as a pharmaceutical company that manufactures and markets prescription, consumer healthcare, and personal care products in the Philippines. It offers allergy, body and muscle pain, children’s health, cough and cold, gut/stomach health, healthy aging/senior care, men’s health, skin care, sports nutrition, and women’s health and beauty products; headache, fever, and flu products; and vitamins and supplements. Unilab (Philippines) Inc. was formerly known as United Laboratories, Inc. The company was founded in 1945 and is headquartered in Mandaluyong City, the Philippines.

66 United Street

Mandaluyong City,  1550

Philippines

Founded in 1945

Phone:

63 2 858 1000

Fax:

63 2 637 1635

Key Executives for Unilab (Philippines) Inc.

Chief Executive Officer and President
Age: 45
Senior Vice President of R&d
Assistant Vice President and Country General Manager of Myanmar
Compensation as of Fiscal Year 2016.

Unilab (Philippines) Inc. Key Developments

GenoVive Signs Partnership with FitLab to Bring DNA Personalized Nutrition to Southeast Asia

GenoVive announced a new partnership with FitLab, a division of Unilab, Inc., to offer its personalized health program in Southeast Asia. With this new partnership, GenoVive has a global presence now in five countries, including Philippines, Brazil, Dominican Republic, Mexico and Saudi Arabia.

United Laboratories and Debiopharm International Launch Pamorelin in the Philippines

United Laboratories (Philippines) and Debiopharm International (Switzerland) have entered into an distribution and commercialisation agreement for Pamorelin (triptorelin pamoate) in the Philippines, for the treatment of locally advanced and metastatic hormone-dependent prostate cancer; as an adjuvant to radiotherapy in high-risk localised and locally advanced prostate cancer and endometriosis.

Nipro Pharma Enters Partnership with United Laboratories to Target Asian Market

Nipro Pharma has entered a collaboration with United Laboratories (Philippines) to market the Japanese company's pharmaceutical treatments in the Asian market. Under the agreement, United Laboratories will first market Nipro's products in the Philippines. The partnership is expected to be positive for Nipro and United Laboratories. Nipro will be able to leverage the extensive network of United Laboratories, which is the Philippines' larger pharmaceutical firm. Both companies are aiming to tap rapidly growing demand for affordable and safe generics in the Philippines, which has seen other firms pile into the increasingly competitive space.

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Unilab (Philippines) Inc., please visit www.unilab.com.ph. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.